Phase II study of bortezomib-dexamethasone alone or with added cyclophosphamide or lenalidomide for sub-optimal response as second-line treatment for patients with multiple myeloma
| Image |  |
|---|---|
| Description | scientific article |
| Author/s |
author: Huw Roddie Athanasios Dimopoulos Lotfi Benboubker Thierry Facon Meral Beksac |
| Publication date | May 28, 2013 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |